WHO Sounds Alert Over Acute Lack of Obesity Injections
Under a tenth of people eligible to benefit from weight-loss injections like Wegovy can access them, warns the global health agency as it publishes its inaugural advice on the therapies.
Given in excess of 1,000,000,000 individuals worldwide currently obese, it is advocating for increased and just availability to GLP-1 medication.
Based on estimates, more than two billion are projected to be obese by 2030 if no action is taken.
"Our latest guidance acknowledges that excess weight is a long-term condition that can be managed with comprehensive and continuous treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and logistical bottlenecks are key barriers to widespread availability to the injections that can help people shift significant body mass, explains the organization.
Skinny Jab Supply Crisis
Even in the present best projected scenario, the production of these medications might only reach approximately 100 million people – less than 10% of the global need, as stated by the WHO.
The advice calls on nations and manufacturers to expand availability, through measures like patent sharing.
Exclusive production rights on a key compound – the primary component of a leading brand – is set to lapse in multiple countries in 2026.
The Way Obesity Jabs Function
The injections imitate a body's own hormone to reduce digestion speed, curb appetite and boost feelings of fullness so people consume fewer calories.
People usually begin shedding pounds in the initial weeks of starting on the regular doses.
Evidence indicates people may see weight return within a year of halting the medication, because their normal hunger come back.
To be overweight or obese elevates your likelihood for contracting diseases, including diabetes, heart disease, brain attack, and certain malignancies.
Obesity affects individuals in countries worldwide and was associated with 3.7 million deaths worldwide in 2024, according to the health agency.